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ABSTRACT
In the mammalian mitochondrial translation appar-
atus, the proteins and their partner RNAs are coded
by two genomes. The proteins are nuclear-encoded
and resemble their homologs, whereas the RNAs
coming from the rapidly evolving mitochondrial
genome have lost critical structural information.
This raises the question of molecular adaptation of
these proteins to their peculiar partner RNAs. The
crystal structure of the homodimeric bacterial-type
human mitochondrial aspartyl-tRNA synthetase
(DRS) confirmed a 3D architecture close to that of
Escherichia coli DRS. However, the mitochondrial
enzyme distinguishes by an enlarged catalytic
groove, a more electropositive surface potential
and an alternate interaction network at the
subunits interface. It also presented a thermal sta-
bility reduced by as much as 12C. Isothermal titra-
tion calorimetry analyses revealed that the affinity
of the mitochondrial enzyme for cognate and non-
cognate tRNAs is one order of magnitude higher,
but with different enthalpy and entropy contribu-
tions. They further indicated that both enzymes
bind an adenylate analog by a cooperative allosteric
mechanism with different thermodynamic contribu-
tions. The larger flexibility of the mitochondrial
synthetase with respect to the bacterial enzyme, in
combination with a preserved architecture, may rep-
resent an evolutionary process, allowing nuclear-
encoded proteins to cooperate with degenerated
organelle RNAs.
INTRODUCTION
Mitochondria are of endosymbiotic origin and have
undergone massive gene transfer to the host nucleus
during evolution (1). On sharp reduction (70-fold) to a
16.6 kb circular mammalian mitochondrial (mt) DNA,
only 37 genes remain coding for 13 respiratory chain
subunits, 22 tRNAs and 2 rRNAs (2). The faster evolu-
tionary rate of mt-DNA than the nuclear genome (3,4)
leads to abnormal RNAs, shrunken in size and often
lacking important signals. mRNAs are deprived of
30- and 50-untranslated regions, rRNAs are smaller than
their bacterial or eukaryotic homologs, and an RNA
moiety for RNase P is absent (5–7). Most mt-tRNAs
have shortened sequences, miss crucial folding and recog-
nition nucleotides as compared with ‘classical’ tRNAs and
are more ﬂexible (6,8–10). Hence, preservation of mito-
chondrial translation relies on a continued adaptation of
proteins to the peculiarities of partner RNAs. One com-
pensatory mechanism consists in an increase in the
number and/or size of partner proteins (encoded in the
nucleus and imported) that take over the role of missing
RNA domains. For instance, bovine mt-ribosomes
contain 30 proteins in the small subunits and 48 in the
large subunits, instead of 21 and 33, respectively, in pro-
karyotes, with N- or C-terminal extensions (11,12).
Human RNase P is fully proteinaceous with three
protein subunits (7).
Mechanisms to compensate for degeneration of
mammalian mt-tRNAs remain mainly unsolved, espe-
cially for mt aminoacyl-tRNA synthetases (mt-aaRSs;
speciﬁcity indicated by the amino acid abbreviated in a
one-letter code, the origin of the aaRS is indicated by a
three-letter abbreviation of the organism’s name with the
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mitochondrial origin given by the digit 2 e.g. HsaDRS2
for Homo sapiens mitochondrial aspartyl-tRNA
synthetase), the enzymes which activate and bind a
speciﬁc amino acid to their cognate tRNA (13). These
enzymes are nuclear encoded and, with only few excep-
tions, are of about the same size, have the same structural
2D organization and contain the expected speciﬁcity
signals and synthetase class signatures as bacterial and
cytosolic aaRSs (14–17). The ﬁrst 3D structures of mam-
malian mt-aaRSs conﬁrmed the absence of additional
domains (18–21).
Properties of mammalian mt-aaRSs enabling them to
deal with mt-tRNAs remain mainly unknown (9,22,23).
On one side, their catalytic efﬁciency is usually one to
two orders of magnitude below that of bacterial aaRSs,
aminoacylation identity rules rely either on minimalist sets
of determinants in the tRNA or even are disobeyed
(22,23). On the other hand, a long standing remarkable
feature of mt-aaRSs is their high capacity in tRNA
accommodation: mt-aaRSs charge both mt- and
bacterial tRNAs, whereas bacterial aaRSs cannot cross-
aminoacylate mt-tRNAs (24). Non-aminoacylation of an
mt-tRNA by a bacterial enzyme is linked to the absence
of essential identity signals and to the large ﬂexibility of
the mt-tRNA (25). These data suggest the existence of
peculiar dynamic properties for the mt-aaRSs, which are
not shared with a bacterial homolog.
Here, we compared several biophysical properties
of human mitochondrial aspartyl-tRNA synthetase,
HsaDRS2, with them to those of a bacterial (E. coli)
homolog, EcoDRS. The crystal structure of HsaDRS2
was solved, thermal stabilities were quantiﬁed, and
thermodynamic parameters of substrate binding were
determined by isothermal titration calorimetry. As an
outcome, both proteins share a common 3D architecture
but the mammalian mt-aaRS gained in plasticity, enabling
it to handle any tRNAAsp and especially the non-
canonical mt-tRNAAsp. We propose that enlarged plasti-
city represents a co-evolution mechanism of the nuclear
and mt genomes in eukaryotic cells subjected to highly
different evolutionary pressures. This plasticity will be
an important parameter to consider for the molecular
understanding of a rapidly increasing number of human
disorders linked to mutations in mt-aaRSs.
MATERIALS AND METHODS
Protein and tRNA puriﬁcation
EcoDRS was overproduced in E. coli JM83, puriﬁed
to homogeneity and concentrated to 40mg ml1 (25).
HsaDRS2 [mt-AspRS(I41) in (26); Supplementary
Figure S1] was cloned into pDEST14 using the Gateway
technology (Invitrogen) and overproduced in E. coli BL21
(DE3) Rosetta 2 strain as described (26). It was puriﬁed by
afﬁnity chromatography on an Ni-NTA column followed
by gel ﬁltration and concentrated to 20 mg ml1 (concen-
tration of monomers) in 50mM of HEPES–Na pH 7.5,
150mM of NaCl, 1mM of DTT, 0.1mM of ethylenedia-
minetetraacetic acid and 10% (v/v) of glycerol. This
buffer, called herein ‘isothermal titration calorimetry
(ITC) buffer’, prevents denaturation of the mt-aaRS for
several days as veriﬁed by dynamic light scattering (DLS)
(Supplementary Figure S2). Magnesium had to be kept
out, as even low concentrations led to precipitation
of HsaDRS2. It was also used for the preparation of
EcoDRS and of the tRNAs. tRNAs (sequences are
indicated in Supplementary Figure S1) were produced by
in vitro transcription and were puriﬁed to single nucleotide
resolution on denaturing 12% polyacrylamide gel electro-
phoresis. They were solubilized in ITC buffer and
denatured/renatured before use as described (16).
Aminoacylation
Assays were performed at 25C on transcripts as described
previously (16,27). Speciﬁc activities were measured by
incubating 0.2–3 nM EcoDRS or 77–930 nM HsaDRS2,
with an excess of 4 mM cognate or non-cognate transcript.
Kinetic parameters kcat and KM were derived from assays
containing 2 nM of EcoDRS or 50 nM of HsaDRS2 with
0.2–4 mM of Eco tRNAAsp or mt-tRNAAsp transcript.
Crystallography
Crystallization conditions were searched at 20C using
commercial kits as described (26). HsaDRS2 was
crystallized by vapor diffusion with 10% (m/v)
PEG-3350 and 0.5M of ammonium sulfate as crystallants
in 25mM of Bis–Tris pH 5.5 (26). Resulting needle-like
crystals (300 20 20 mm3) were cryocooled in their
mother liquor. They were extremely radiation sensitive
and diffracted weakly. Complete data sets were collected
with a fast PILATUS 6M pixel detector (DECTRIS) at
the X06DA beamline, Swiss Light Source (Villigen).
Diffraction data at 3.7A˚ resolution in P2 space group
were processed using XDS and XSCALE (28) and were
converted into structure factors without any sigma cut-off
using TRUNCATE from the CCP4 package (29).
Molecular replacement solutions were sought with data
truncated at 4.5 A˚ using a homology model derived from
the structure of EcoDRS (30) and the PHASER program
(31) as implemented in the PHENIX package (32).
Two HsaDRS2 dimers were identiﬁed in the monoclinic
asymmetric unit. Reﬁnement using a dynamic elastic
network (DEN) as implemented in CNS 1.3 (33) led to
a reorientation of the insertions and to a dramatic im-
provement of the electron density map. All residues of
HsaDRS2 were built except the 26 C-terminal amino
acids (including the 6-His tag), which are disordered.
The ﬁnal coordinates (residues 42–630 for each of the
four monomers) and the experimental data have been
deposited with the PDB (ID: 4AH6). Figures were
prepared with Pymol (www.pymol.org), electrostatic
surface potentials were calculated using its APBS plug-in
and are depicted at the same color scale in all ﬁgures.
Dynamic light scattering
Particle size analysis was performed at 25C using a
Malvern Zetasizer NanoS instrument and a 40 ml quartz
cell containing 20 ml of protein solution at 0.5–8 mg ml1
in ITC buffer. Five consecutive measurements were col-
lected in automatic mode, and data were processed with
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the manufacturer’s software. The hydrodynamic diameter
dh was derived from diffusion coefﬁcient via the Stokes–
Einstein relation and was corrected for solvent viscosity
and refractive index. Thermal stability was estimated by
subjecting protein at 3mg ml1 to temperature gradients
from 20C to 80C. The temperature at which particle size
was increased by a factor 2 was taken as the melting point
Tm. Additives were prepared in water.
Differential scanning ﬂuorimetry
Samples made of 20 ml protein solution at 3mg ml1 and
0.5ml of SYPRO OrangeTM 5000 stock diluted 20-fold
in dimethlsulfoxyde (DMSO) were transferred in 0.2ml
tubes. Additives prepared as described earlier in the text
were brought in 1 ml samples, so that their ﬁnal concentra-
tion was as indicated. The variation of ﬂuorescence inten-
sity during a temperature gradient from 25C to 95C was
monitored in a Stratagene Mx3005P quantitative polymer-
ase chain reaction instrument. On unfolding of the
protein, hydrophobic residues become accessible to the
dye, which becomes ﬂuorescent (34). Melting point Tm
was deduced from maximum of the derivative plot. They
are 5C higher as compared with data obtained by the
DLS method.
Synchrotron radiation circular dichroism
The experimental set-up at the DISCO beamline, SOLEIL
synchrotron (Saint-Aubin, France) was calibrated for
magnitude and polarization with a 6.1mg/ml
D-10-camphorsulfonic acid solution. Ten micrograms
per milliliter of DRS solutions in 100mM of potassium
phosphate, 50mM of KCl, 10% (v/v) of glycerol and
1mM of Tris(2-carboxyethyl)phosphine hydrochloride,
TCEP, were placed in a CaF2 cuvette, with an optical
path of 8 mm. Three spectra between 170 and 280 nm
were recorded at temperatures ranging from 20C to
80C by 4C steps to assess the thermal stability of
EcoDRS and HsaDRS2. Data were processed (spectrum
averaging and solvent baseline subtraction) using CDtool
(35).
Isothermal titration calorimetry
Before ITC measurements, conditions were determined in
which the four investigated macromolecules (HsaDRS2,
EcoDRS, Hsa mt-tRNAAsp and Eco tRNAAsp) were
stable during the time of the experiment. This was found
to be the case in the so-called ‘ITC buffer’ (50mM of
HEPES–Na pH 7.5, 150mM of NaCl, 1mM of DTT,
0.1mM of ethylenediaminetetraacetic acid and 10% of
glycerol). Magnesium had to be omitted, as it leads to
precipitation of HsaDRS. To eliminate possible errors to
ITC experiments, all samples (proteins and tRNAs) were
extensively and extemporaneously dialyzed against a same
stock solution of ‘ITC buffer’, degassed with argon and
ultracentrifuged at 4C. ITC experiments were performed
at 25C in a MicroCal iTC200 instrument (GE Healthcare).
In a typical experiment, 2 ml samples of 300 mM EcoDRS
or of 100 mM HsaDRS2 were injected into 200 ml of 36 mM
or 11 mM, respectively, cognate tRNA transcript solution.
Injections lasted 4 s at 120 s intervals. Cross-bindings were
also performed with protein/RNA concentration in a
10:1 molar ratio. Retrieved H and G values were
used to calculate the binding entropy S (expressed as
TS, with G=HTS). The adenylate analog
50-O-[N-(L-aspartyl)sulfamoyl] adenosine (Asp–AMS)
was titrated against 200ml of enzyme with 0.7ml injections
to HsaDRS2 at 32 mM and 1.5 ml to EcoDRS at 45 mM.
Data were analyzed with the Origin software.
RESULTS
Solution properties of HsaDRS2
HsaDRS2 and EcoDRS are homologous dimeric enzymes,
both of bacterial evolutionary type, sharing a same size
and 43% sequence identity, including all typical signature
motifs of DRSs and the same secondary structure organ-
ization (16,36) (Supplementary Figure S1). Recombinant
proteins were overexpressed in E. coli and the ﬁnal enzym-
atic preparations brought into the same buffer (‘ITC
buffer’, see ‘Materials and Methods’ section) suitable for
ultimate comparative isothermal titration calorimetry ex-
periments. These conditions were a compromise for
non-aggregation of HsaDRS2, the more sensitive of the
two enzymes (27), preservation of activity for both
enzymes and stability of the tRNAs. HsaDRS2 studied
herein is deprived of the 40 ﬁrst amino acids likely encom-
passing the mitochondrial targeting sequence (26). Both
proteins had the same mean hydrodynamic diameter (dh)
of 10±1nm in DLS, in agreement with a homodimeric
structure (Supplementary Figure S2). Kinetic parameters
and catalytic efﬁciencies of both enzymes tested under
identical conditions conﬁrmed the 60-fold higher
aminoacylation rate and efﬁciency in the EcoDRS
cognate system compared with HsaDRS2 (Table 1).
However, EcoDRS was unable to aminoacylate the
mt-tRNA, whereas the mt-aaRS charged both cognate
and non-cognate tRNAs with similar efﬁciency.
Crystal structure of HsaDRS2
Single needle-like crystals of HsaDRS2 were obtained in
the presence of PEG-3550 and ammonium sulfate (26).
They yielded a complete diffraction data set (26). In
spite of their modest resolution (3.7 A˚), these data were
suitable to determine the architecture of HsaDRS2 (26).
The structure, solved herein by molecular replacement
using a homology model derived from the structure of
the EcoDRS (30), conﬁrmed the dimeric status of the
enzyme. It clearly showed the anticodon binding and cata-
lytic domains of the monomers but did not enable visual-
ization of the bacterial insertion domain (residues
337–470, Supplementary Figure S1). This suggested
either a structural rearrangement or a local ﬂexibility of
this domain. The ambiguity was solved by using a
DEN-assisted reﬁnement procedure (33) that allowed re-
positioning of the insertion in well-deﬁned electron density
(Supplementary Figure S3 and Table 2). This domain re-
orientation, different from EcoDRS, was not an effect of
crystal packing because the four independent monomers
in the asymetric unit adopted the same conformation.
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Altogether, 96% of the sequence of the crystallized
homodimeric HsaDRS2 is seen (Figure 1A), with a
slight asymmetry between its two subunits because of vari-
ations in the bacterial insertion domain (Supplementary
Figure S4 and Supplementary Table S5). Overall, the
architecture of HsaDRS2 is similar to that of bacterial
DRSs, in agreement with sequence conservation (16,36).
Comparison with EcoDRS crystal structure (30) high-
lighted a strong conservation. Respective DRS cores,
including the anticodon-binding domain, which adopts
the so-called OB fold (for oligonucleotide-binding fold),
the hinge region and the catalytic domain with its charac-
teristic antiparallel b-sheet (30,38) displayed an over-
all rmsd (root mean square distance) of 2 A˚
(Supplementary Table S5). These three domains shared a
similar position with respect to the dimer interface. The
main difference between the two aaRSs resulted from the
bacterial insertion that underwent a rigid-body counter-
clockwise rotation of 26 and clearly made the mito-
chondrial active site more open for the binding of tRNA
(Figure 1B and C). The overall fold of the insertion
remained unchanged. This reorientation explains why
the insertion was barely visible on the initial maps.
Minor conformational diversity occurred in protein
segments that diverge in sequence, located in the periphery
of the catalytic domain, the ﬂipping loop and the motif
2 loop (short insertions/deletions, see Supplementary
Figure S1), which are extremely mobile in DRSs (39,40).
Based on the structural knowledge on human mt-
tRNAAsp (41) a model of the complex with HsaDRS2
could be built (Figure 2) and allowed for comparison
with the bacterial complex. Notable alterations in the
charge distribution within the tRNA interaction surface
of the proteins were observed. Electropositive patches
render HsaDRS2 more attractive for its RNA partner
(Figure 2), similar to what was observed in the three
other mt-aaRS crystal structures solved so far (18–21)
(Figure 5). Ten additional basic residues (nine Lys and
an Arg highlighted in blue in Supplementary Figure S1)
are inserted in the close neighborhood of HsaDRS2 cata-
lytic cleft. They may contribute to make the surface more
attractive or directly contact the tRNA backbone, espe-
cially in the hinge region where such kind of aspeciﬁc
interactions with the D-stem was described in the E. coli
complex (30). Otherwise, almost all residues making direct
and speciﬁc interactions with bases at both ends of the
Eco tRNA are conserved in the human enzyme (indicated
in green in Supplementary Figure S1). This is true for
E270/R271/R274 or R599, which may contact C74 or nu-
cleotides 69–70, respectively, as well as for Q129/E140,
R75/Q91/R125, R125, which are adequately positioned
to interact with the anticodon bases C34, U35 and G36,
respectively. A few residues (indicated in orange in
Supplementary Figure S1) differ without major implica-
tion for the conservation of the interaction network.
Thus, the main modiﬁcation is the presence of a Gly at
position 269, instead of the usually conserved Asp, which
accounts for the insensitivity of HsaDRS2 to the nature
of the discriminator base 73 (42).
The dimeric interfaces of both DRSs differ notably by
the distribution and nature of subunit/subunit contacts
(Supplementary Figure S6). In total, 70 hydrogen bonds
Table 2. Crystallographic analysis of HsaDRS2
Data collection statistics
Beamline SLS/X10A
Space group (number) P2 (3)
Unit cell lengths a, b, c (A˚) 142.4, 82.6, 146.3
Unit cell angles a, b, g () 90, 100.4, 90
Resolution range (A˚) 82–3.7
Highest resolution shell (A˚) 3.8–3.7
Number of observations0 255 882 (9662)
Number of unique reﬂections 35 768 (2403)
Completeness (%) 98.8 (91.2)
Multiplicity 7.2 (4.0)
Rmerge/Rmeas (%)
a 18.0 (63.9)/19.4 (72.5)
<I/(I)> 9.4 (2.1)
Crystal mosaicity () 0.25
Asymmetric unit content 2 dimers
Solvent content (%) 62
Reﬁned atomic structure
Resolution range (A˚) 30–3.7
R-factor/R-free (%) 22.1/28.0
Number of protein residues/atoms 4 589/18 840
Rmsd and bonds (A˚) and angles () 0.005/1.08
Ramachandran plotb residues in most
favored unfavored regions (%)
89.2/0.2
PDBid 4AH6
Values in parentheses are for the highest resolution shell.
aRmerge=hkl i jIi(hkl)<I(hkl)>j/hkl i Ii(hkl) and redundancy-
independent; Rmeas=hkl (n/n-1)
1/2 i jIi(hkl)<I(hkl)>j/hkl i
Ii(hkl).
bAnalysis carried out with Molprobity in Phenix package.
Table 1. Comparative kinetic properties of HsaDRS2 and EcoDRS in tRNA aspartylation
DRSa tRNAAsp (transcript) kcat (10
3 sec1) KM (mM) kcat/KM (10
3 sec1mM1) L Gb (kcal mol1)
HsaDRS2 mt 4.0±0.4 1.1±0.2 3.7±0.7 72 2.45
HsaDRS2 Eco 10.3±2.0 1.2±0.1 8.3±0.8 35 2.04
EcoDRS Eco 230±6.0 0.8±0.1 293±14.4 1 –
EcoDRS mt nd nd nd >106
All data were obtained at 25C (T=298K) and correspond to mean values from at least duplicated experiments with independent and freshly
prepared enzyme and tRNA lots.
akcat and KM values were derived from assays containing 2 nM of EcoDRS or 50 nM of HsaDRS2 and 0.2–4 mM of Eco or Hsa mt-tRNA transcript.
L stands for the relative loss in aminoacylation efﬁciency referred to the tRNA aminoacylation efﬁciency of EcoDRS for Eco tRNAAsp [L= (kcat/
KM)Eco system/(kcat/KM)other]; bG is the variation of the free energy change at the transition state when comparing aminoacylation in the
homologous Eco system with the reactions in the heterologous or Hsa mt-systems [G=RT lnL] (37); nd for not detectable.
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and 28 salt bridges stabilize the EcoDRS interface,
whereas HsaDRS2 only contains 60 hydrogen bonds
and 20 salt bridges. Considering a 10% larger interface
area (5500 versus 5100 A˚2), the contribution of speciﬁc
interactions is 25% lower per A˚2, whereas the contribution
of aspeciﬁc van der Waals interactions is increased,
which may on average lead to a less cohesive HsaDRS2
dimer.
Altogether, the crystal structure of HsaDRS2 reveals
that it shares the same global architecture with EcoDRS
but differs by an enlarged catalytic groove, by a more
electropositive surface potential and by a modiﬁed
network of interactions in the dimer interface.
Temperature stability of HsaDRS2 versus EcoDRS
The sensitivity of both proteins to temperature has been
compared using DLS and differential scanning ﬂuorimetry
(Figure 3 and Supplementary Figure S7). HsaDRS2
unfolded at a temperature of >12C below that of
EcoDRS, in the 37C–45C range, under various biochem-
ical conditions and in the presence of various additives.
This result is supported by sets of synchrotron radiation
circular dichroism spectra recorded at temperatures from
20C to 80C (Supplementary Figure S8). For both
proteins, a transition from an ordered to a disordered
state occurs at temperatures similar to those observed in
DLS and differential scanning ﬂuorimetry. This low
melting temperature was also valid for an HsaDRS2
variant bearing different N- and C-terminal amino acids
but not for HsaYRS2, which melted at 55C
(Supplementary Figure S7). Signiﬁcant stabilization was
observed in the presence of Asp–AMS [(50-O-[N-(L-
aspartyl)sulfamoyl]adenosine; Glu-AMS, Gln-AMS, Tyr-
AMS for other sulfamoyl-adenylates; AspOH, GluOH,
TyrOH for amino alcohol-adenylates], a high afﬁnity
analog of the aspartylation reaction transition state (43),
but neither in the presence of tRNA, adenosine triphos-
phate or aspartic acid did (Figure 3 and Supplementary
Figure S7). Asp–AMS had a speciﬁc effect at a 1:1 stoi-
chiometry per monomer (not shown), suggesting that it is
binding to the catalytic site and that this binding protects
the protein from melting. Stabilization of aaRSs by
binding of adenylate analogs has been taken advantage
for successful crystallization (44). Herein, we observe sta-
bilization against temperature induced melting. Along
initial attempts to stabilize HsaDRS2 by site-directed mu-
tagenesis, the replacement of amino acids of the hinge
domain by those of EcoDRS led to a gain of 5C in Tm
(Supplementary Figure S7).
Figure 1. Newly solved 3D structure of HsaDRS2 in comparison with
EcoDRS. (A) Cartoon representation of HsaDRS2 dimer. Characteristic
DRS domains are highlighted in the left monomer: anticodon binding
domain in yellow, hinge region in orange, catalytic domain in red and
bacterial insertion in violet. The right monomer is displayed in black with
position of residues conserved in HsaDRS2, and EcoDRS is colored in
green. Sequence identity is 40% overall, 47% in the catalytic domain,
41% for the anticodon-binding domain and drops to 25% in the inser-
tion. (B) Superposition of DRS monomers: HsaDRS2 chain colored as
in (A), E. coli free (PDBid: 1EQR) and tRNA-bound (PDBid: 1C0A)
monomers in light and dark blue, respectively. The bacterial insertion
in HsaDRS2 is rotated by 26 compared with its position in EcoDRS
(see arrow). Bottom left: zoom on superposed insertions illustrating
the overall fold conservation. (C) Zoom on the active site groove with
same color code for DRSs as in (B), and Eco tRNA is represented
as a semi-transparent orange backbone. The distance between two
conserved residues (in green) on each side of the groove is displayed:
Phe390 in HsaDRS2 (Phe340 in EcoDRS) in the external helix of the
Figure 1. Continued
insertion and Arg271 (Arg222) in the motif 2 loop of class II
synthetases. The 26 reorientation visualized by the movement of the
axis of the external helix opens up the groove for the tRNA acceptor
arm by 7–10 A˚ in HsaDRS2 when compared with the tRNA bound and
free states of EcoDRS.
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Thermodynamics of tRNA binding to HsaDRS2 versus
EcoDRS
ITC (45) was used to gain insights into the thermo-
dynamics of tRNAAsp binding to DRSs. In vitro tran-
scribed tRNAs were used, as access to milligram
amounts of native human mt-tRNAs remains out of
scope (9). Mt-tRNAAsp distinguishes drastically from bac-
terial tRNAAsp by primary, secondary and tertiary struc-
tural elements (Supplementary Figure S1), leading to the
absence of major aspartate identity elements and to a
larger structural ﬂexibility (25). Typical thermodynamic
data are presented in Figure 4 and summarized in
Table 3. Under the tested conditions, the afﬁnities of
HsaDRS2 for either mt- or Eco tRNAAsp were in the
same range (Kd 250 nM), whereas binding of EcoDRS
to its cognate tRNAAsp was weaker by one order of mag-
nitude (Kd of 3 mM) and binding to the non-cognate
mt-tRNAAsp dropped the afﬁnity by two orders of
magnitude (Kd of 22 mM). Enthalpy and entropy contribu-
tions distinguished mitochondrial and bacterial cog-
nate complex formation. HsaDRS2/mt-tRNAAsp was
accompanied by about twice as large contributions of
both parameters than EcoDRS/Eco tRNAAsp formation.
However, both values compensated each other to similar
extents, leading to similar variations in free energy namely
G=9.1 kcal/mol and 7.5 kcal/mol, respectively. The
difference between these free energies (G=1.6 kcal/
mol) is in agreement with a G of 2.45 kcal mol1
measured by comparative kinetic properties of both
aaRSs at the transition state (Table 1, 3, and 4).
Thermodynamic parameters for non-cognate complex
formation (cross-complexes) revealed a pre-eminent role
of the tRNA partner as compared with the synthetases
(Table 4 and Figure 4A and B). Similarly, low binding
enthalpies and entropies drive complexes involving the
structurally stable Eco tRNAAsp regardless the enzyme.
At opposite, binding of the unstable and highly ﬂexible
mt-tRNAAsp required far larger enthalpic and entropic
compensations, regardless the enzyme. These large
values are indicative of the adaptation of mt-tRNAAsp
to both enzymes’ surfaces involving likely conformational
changes of the tRNA, releasing of water molecules along
the binding surface and reciprocal adaptation of the
nucleic acid and the protein.
Figure 2. Comparison of HsaDRS2 (left) and EcoDRS (right) surface potentials. Surface potentials are depicted from positive to negative in blue to
red with the same color scale. (A and B), tRNA-bound HsaDRS2 (model) and EcoDRS (PDBid: 1C0A) with tRNAAsp (shown in purple). (C) The
enzymes without tRNA. In (A), the complexes are observed along their two-fold symmetry axis. In (B and C), they are rotated as indicated to better
visualize the interaction zone on the surface of the left monomer. The right monomer is colored with hydrophobic patches in green.
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Thermodynamics of adenylate analog binding to
HsaDRS2 versus EcoDRS
Binding of the adenylate analog Asp–AMS to the two
dimeric DRSs revealed two different binding sites within
each DRS dimer (Figure 4 and Table 4). For both
enzymes, a ﬁrst adenylate bound to one monomer (n
0.5, i.e. 0.5mol of adenylate per mol of monomer) with
low afﬁnity (Kd of 129nM for HsaDRS2 and 29.5nM for
EcoDRS). The second adenylate bound then to the second
site with a higher afﬁnity (Kd of 17.5nM forHsaDRS2 and
of 2.95nM for EcoDRS), in favor of a positive-allosteric
event. The gain in afﬁnity for the second binding site was of
similar amplitude (5- to 10-fold) in both enzymes, and
afﬁnities (in the nM range) were in agreement with the pre-
viously measured Ki values for HsaDRS2 (43). Binding of
Asp–AMS to each monomer, however, followed a different
thermodynamic route depending on the considered enzyme.
For EcoDRS, binding was both enthalpy- and entropy-
driven. In contrast, binding to HsaDRS2 was strongly
enthalpy-driven. This different thermodynamic signature
supports different binding mechanisms of Asp–AMS to
HsaDRS2 and to EcoDRS.
DISCUSSION
‘Same–same but different’
The crystal structure of HsaDRS2 revealed a typical
overall bacterial-type DRS architecture (30, 38–40) that
superimposes with the structure of EcoDRS with a
global rmsd <2 A˚ (Figure 1). The two functionally import-
ant domains, catalytic site and anticodon-binding domain
overlap with an rmsd of <1.5 A˚. The important differences
between the two structures are (i) the angle formed by the
Figure 4. Isothermal titration calorimetry of HsaDRS2 and EcoDRS
to tRNAs and to the adenyate analog Asp–AMS. (A) Titration of
in vitro transcribed tRNAs by HsaDRS2. (B) Titration of in vitro
transcribed tRNAs by EcoDRS. (C) Titration of EcoDRS and
HsaDRS2 by Asp–AMS.
Figure 3. Thermostability of HsaDRS2 and EcoDRS. Melting tempera-
tures as measured by DLS. (A) Thermostability of HsaDRS2 (dashed
black line) compared with EcoDRS (black line). (B) The presence of
in vitro transcribed Hsa mt-tRNAAsp (light grey) or Eco tRNAAsp (dark
grey) (in 1.2-fold molar excess) did not signiﬁcantly inﬂuence the
thermostability of either DRS. (C) Among the small substrates, only
Asp–AMS (dashed grey line) inﬂuences the thermostability of the two
enzymes positively [aspartic acid: black line, adenosine triphosphate
(ATP): grey line, AspOH: light grey line]. Denaturation temperatures of
duplicates performed with different enzyme preparations differed by 2C.
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prokaryal-speciﬁc insertion domain and the catalytic
domain, which is more opened by 26 in the mt-aaRS;
(ii) the overall electropositive surface potential (as
observed for other mammalian mt-aaRSs); and (iii) the
dimer interface, which is weaker in terms of salt-bridges
and hydrogen bonds.
A distinguishing property between the two proteins is the
unprecedented observation for a human mt-aaRS to melt
at near body temperature (37C) and 12C lower than
EcoDRS, in line with a restricted thermo-tolerance of the
translation and replication processes in mitochondria (46).
It is likely that the weakened dimer interface is one of the
contributors to this fragility. Fine prediction of the molecu-
lar reasons for the melting temperature of a protein is
difﬁcult and may be dependent on as little as a single
amino acid (47). Interestingly, a thermosensitive mutant
of EcoDRS in which proline 555 was affected, has been
reported (48). The equivalent position in HsaDRS2 has
kept an equivalent proline residue (Pro 605), so that the
contribution of this position to thermosensitivity is ruled
out. We favor the contribution of the hinge domain, as
partial stabilization by mutation in HsaDRS2 was
successful.
ITC was used here for the ﬁrst time on tRNA/synthetase
couples to examine thermodynamics of cognate
mt-tRNAAsp and non-cognate Eco tRNAAsp interactions.
When tested under strictly the same conditions, HsaDRS2
binds both its cognate and non-cognate tRNAAsp with
a same sub-micromolar Kd, whereas EcoDRS binds
cognate Eco tRNAAsp in the low micromolar range and
non-cognate mt-tRNAAsp in the high micromolar range.
It is anticipated that the parameters would be closer to,
but still distinct, from those for the bacterial cognate
pair when measured with native post-transcriptionally
modiﬁed tRNAs. Indeed, modiﬁcations are known to
stabilize structures (49), but the modiﬁcation pattern of
mt-tRNAAsp is far beneath that of Eco tRNAAsp (see
Supplementary Figure S1). Binding between cognate mito-
chondrial partners requires large enthalpic and entropic
compensations at opposite to binding between the
cognate bacterial partners where compensations were
small. Cross-binding revealed that this difference is
mostly linked to the tRNA. Binding of the ﬂoppy
mt-tRNA involved large positive enthalpic and large
negative entropic contributions, whereas binding of the
well-folded and stable Eco tRNA involved low enthalpy/
entropy compensations. These results are in line with
thermodynamic parameters determined for cognate and
non-congate tRNA/synthetase couples measured earlier
by ﬂuorescence titrations and fast kinetic techniques
(50,51).
Altogether, comparative investigation of biophysical
properties of HsaDRS2 and EcoDRS shed new light on
the long-term open question as to non-reciprocal amino-
acylation of bacterial and mitochondrial tRNA/
synthetase pairs (24). They revealed that the human
enzyme has gained structural adaptability to tRNA sub-
strates by combining several properties. A more electro-
positive tRNA-binding surface [see also (52)] and an
opening of the cleft between the insertion domain and
the catalytic domain by an angle of as much as 26
improve accessibility and binding of the tRNA end to
the catalytic site. Strong binding likely reﬂects an evolu-
tionary adaptation of the mt-aaRS to compensate for
high ﬂexibility of the mt-tRNA and for the absence of
otherwise important identity elements. Whether the
Table 3. Comparative thermodynamic properties of HsaDRS2 and EcoDRS: thermodynamic parameters of DRS interaction with tRNA, as
measured by ITC
DRS+tRNA(transcripts) na Kd (mM) H (kcal mol
1) TS (kcal mol1) G (kcal mol1)
HsaDRS2+Hsa mt-tRNAAsp 0.48±0.26 0.26±0.18 20.3±0.7 +11.2±0.4 9.1±0.5
HsaDRS2+Eco tRNAAsp 0.87±0.16 0.24±0.01 14.0±0.7 +5.0±0.7 9.0±0.5
EcoDRS+Eco tRNAAsp 0.76±0.01 3.1±0.1 13.0±3.1 +5.5±3.2 7.5±0.5
EcoDRS+Hsa mt-tRNAAspb 0.39±0.02 22.0 30.8 +24.4 6.4
All data were obtained at 25C (T=298K) and correspond to mean values from at least duplicated experiments with independent and freshly
prepared enzyme and tRNA lots.
an stands for the number of moles of Asp–AMS bound per mole of DRS monomer.
bCross-binding between EcoDRS and Hsa mt-tRNAAsp performed only once.
Table 4. Comparative thermodynamic properties of HsaDRS2 and EcoDRS: thermodynamic parameters of DRS interaction with Asp–AMS, as
measured by ITC
DRS+Asp-AMS na Kd (nM) H (kcal mol
1) TS (kcal Mol1) G (kcal mol1)
HsaDRS2–monomer 1 0.48±0.02 129±38.0 13.18±0.39 +3.9±0.78 9.38±0.18
HsaDRS2–monomer 2 0.29±0.04 17.5±12.0 21.8±0.31 +10.57±0.71 10.63±0.44
EcoDRS–monomer 1 0.49±0.02 29.5±5.0 5.50±0.01 4.75±0.13 10.24±0.10
EcoDRS–monomer 2 0.44±0.01 2.95±1.34 8.16±0.35 3.52±0.61 11.63±0.28
All data were obtained at 25C (T=298K) and correspond to mean values from at least duplicated experiments with independent and freshly
prepared enzyme and tRNA lots.
an stands for the number of moles of Asp–AMS bound per mole of DRS monomer.
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binding step is accompanied by a concerted movement
of the insertion domain towards the catalytic site to
further lock the tRNA, is unknown. The larger structural
plasticity of the mt-aaRS (enabling it to deal with
the highly ﬂexible and degenerated mt-tRNAAsp) does
not harm its interaction with classical and less ﬂexible
Eco tRNAAsp. At opposite, the bacterial aaRS is
unable to bind properly the mt-tRNA. Binding to its
cognate more rigid tRNAAsp is closer to a lock-and-key
type process.
Gain of plasticity as reﬂected here by unusual thermo-
dynamic properties, may be a more general property of
mt-aaRSs that have to deal with degenerated mt-tRNAs.
An extreme case of plasticity has recently been described
with the human mitochondrial FRS that undergoes
dramatic conformation change on tRNA binding (21).
The near-body thermal unstability of HsaDRS2 as well
as its electropositive surface potential suggest that differ-
ent parameters may stabilize the protein in vivo. These
may be of biochemical nature or correspond to co-factors,
partner proteins or peculiar sub-mitochondrial localiza-
tion, as is the case for mt-ribosomes and mt-elongation
factor that bind to the inner membrane (9).
Cooperative allostery in class II dimeric DRSs
A long-standing question for dimeric aaRSs concerns the
communication mechanisms between the two catalytic
sites (13). Data obtained herein by ITC demonstrate un-
ambiguously that both EcoDRS and HsaDRS2 undergo
an allosteric event on binding to the adenylate analog.
The ﬁrst monomer binds the analog with a weaker
afﬁnity than the second monomer. Thermodynamic signa-
tures strongly suggest a different binding mechanism for
each enzyme: interaction with HsaDRS2 is a strongly
exothermic process, characterized by a large negative
enthalpic term, whereas binding to EcoDRS is associated
with moderate enthalpic and entropic contributions.
These differences likely reﬂect large obligatory rearrange-
ments in HsaDRS2 but not in EcoDRS.
Allostery has been reported for several aaRSs (53–56).
Half of the site activity was mainly observed. Herein, we
report direct cooperative allostery for small substrate
binding, as detected by ITC. Previous ITC investigations
performed on other aaRSs had not detected cooperative
allostery (53–56).
CONCLUSION AND PERSPECTIVES
Resolution of the crystal structure and exploration of bio-
physical properties of a human mitochondrial aaRS,
revealed similarities but also distinctive features from a
prokaryotic homolog: a conserved architecture and a
conserved cooperative allosteric communication within
the dimers but also increased structural plasticity. We
propose that the modiﬁcation of intrinsic biophysical
properties and new surface properties, along with conser-
vation of size and structural framework, represents an
evolutionary mechanism for adaptation of nuclear-
encoded proteins to degenerated mitochondrial-encoded
RNAs. This mechanism is alternative to domain extension
and sustains adaptation of two genomes subjected to dif-
ferent evolutionary constraints. The possibility that
mt-aaRSs also undergo functional expansion by structural
inventions and have partner proteins as described for
cytosolic aaRSs (57,58) is not excluded but remains to
be tackled. The properties of an mt-aaRS reported
herein provide new insights towards the understanding
of the growing number of human disorders linked to mu-
tations in the corresponding genes (9,59,60). Deciphering
the ﬁne molecular triggers leading to both speciﬁc (i.e.
plasticity) and shared (i.e. allostery) properties of human
mt-aaRSs, and their evolutionary related homologs
requires delineation of discriminating and
non-discriminating amino acids within the aaRS
Figure 5. Molecular surface potential of bacterial (E. coli or Thermus
thermophilus) and mammalian (bovine or human) mitochondrial aaRSs.
On the left, bacterial complexes (PDBids: 1C0A for EcoDRS/tRNA,
1SRS for TthSRS/tRNA, 2IY5 for TthFRS/tRNA and 1H3E for
TthYRS/tRNA) are shown on the left with monomers A in blue,
monomers B in green and tRNAs in pink, indicating the binding site
of the cognate substrates. In the case of tetrameric bacterial FRS,
monomers C and D are depicted in cyan. The electrostatic surface
potential of free aaRS forms is represented in the same orientation as
the complexes for bacterial (1EQR for EcoDRS, 1SRY for TthSRS,
1B7Y for TthFRS, 1H3F for TthYRS without its C-terminal domain)
and mitochondrial enzymes (this study for HsaDRS2, 1WLE for
BtaSRS2, 3TUP for HsaFRS2, 2PID for HsaYRS2). Overall, the
tRNA binding surface seems to be more electropositive in mitochon-
drial forms, even for FRS, which has a different structural organization
(monomer instead of heterotetramer).
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architecture. Bioinformatic tools enabling such an analysis
are under development.
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